Position in NAGE
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$84,733
-$286,290 QoQ
Shares Held
19,214
-67.1% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. NAGE ranks #227 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in NAGE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $84,733 | 19,214 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $371,023 | 58,337 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $509,389 | 54,597 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $424,143 | 29,434 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $180,490 | 26,158 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $122,857 | 23,137 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $59,425 | 16,281 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $46,070 | 16,876 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,591 | 1,607 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,287 | 1,600 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,304 | 1,579 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,503 | 1,595 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $2,411 | 1,576 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,638 | 1,571 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,884 | 1,532 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,616 | 1,567 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $204,464 | 83,116 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $356,436 | 95,304 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $493,335 | 78,682 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $320,962 | 32,552 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,313,951 | 140,680 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $515,567 | 107,410 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $448,593 | 111,869 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $475,523 | 103,600 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $250,243 | 76,762 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||